Groups | Patients/healthy controls (NO.) | Percentages at + 30 days | Percentages at + 60 days | Percentages at + 90 days |
---|---|---|---|---|
HLA-A*0201 group | ||||
P1 | 0.1982 | 2.9100 | 1.0950 | |
P2 | 0.8337 | 1.9200 | 1.3644 | |
P3 | 0.7296 | 3.0000 | 1.0119 | |
P4 | 0.3252 | 3.1700 | 1.4483 | |
P5 | 0.0179 | 1.9000 | 1.1990 | |
P6 | 1.0790 | 4.2400 | – | |
P7 | 0.5619 | 0.6900 | – | |
P8 | 0.2727 | 0.5300 | – | |
P9 | 0.9600 | 0.5500 | – | |
P10 | 0.8924 | – | – | |
H1 | 2.1000 | |||
H2 | 0.6200 | |||
H3 | 1.5900 | |||
H4 | 5.7900 | |||
H5 | 1.7700 | |||
H6 | 0.3000 | |||
H7 | 2.8800 | |||
H8 | 1.4700 | |||
H9 | 3.4800 | |||
HLA-A*1101 group | ||||
P1 | 2.4667 | 0.0672 | – | |
P2 | 0.3413 | 0.5073 | 0.4926 | |
P3 | 0.1585 | 0.3339 | 0.3434 | |
P4 | 1.2534 | 1.5635 | 1.0086 | |
P5 | 1.0931 | 2.8223 | 1.1053 | |
P6 | 0.2601 | 0.5272 | – | |
P7 | 0.6569 | 0.7229 | 0.4940 | |
P8 | 0.5787 | 1.0769 | – | |
P9 | 0.1537 | 0.8800 | 1.8715 | |
H1 | 3.5392 | |||
H2 | 0.7454 | |||
H3 | 2.1402 | |||
H4 | 3.5406 | |||
H5 | 2.0589 | |||
H6 | 2.7509 | |||
H7 | 6.1721 | |||
H8 | 0.6712 | |||
H9 | 2.7146 | |||
H10 | 2.6164 | |||
H11 | 0.7193 | |||
H12 | 1.4663 | |||
H13 | 0.9191 | |||
H14 | 6.6107 | |||
H15 | 3.5822 | |||
H16 | 3.5711 | |||
H17 | 2.2981 | |||
H18 | 2.6966 | |||
H19 | 2.8326 |